22.03.2005 22:30:00

Jefferies Adds Senior Healthcare Banker; Annette Grimaldi to Lead Firm

Jefferies Adds Senior Healthcare Banker; Annette Grimaldi to Lead Firm's Investment Banking in Life Sciences


    Business Editors/Health Editors

    NEW YORK--(BUSINESS WIRE)--March 22, 2005--Jefferies & Company, Inc., the principal operating subsidiary of Jefferies Group, Inc. (NYSE:JEF), today announced that Annette C. Grimaldi has joined as a Managing Director and head of the firm's investment banking effort in the life sciences area of healthcare. Ms. Grimaldi will focus on biotech and emerging pharmaceutical companies and lead Jefferies' efforts in providing them strategic advisory and capital raising services.
    The healthcare sector has long been one of the firm's areas of focus. Jefferies has six securities traders dedicated to healthcare, and, with inclusion of its European affiliate, eight senior research analysts, including four analysts focused on life sciences and four covering a range of industries within healthcare services.
    "Annette Grimaldi's outstanding experience and deep relationships in life sciences significantly enhance our strong position in serving the healthcare sector," commented Richard B. Handler, Chairman and CEO of Jefferies. "We will continue to build on Jefferies' leading capabilities in all aspects of the capital markets and as a strategic advisor focused on middle market companies."
    "I am delighted to join Jefferies' thriving investment banking group to help build a strong life sciences practice within this dynamic organization," said Ms. Grimaldi. "Jefferies' focus on growing and mid-sized companies and the firm's full product offering are well suited to the life sciences industry."
    Ms. Grimaldi has nearly 18 years experience on Wall Street, the majority being focused in healthcare. Prior to Jefferies, she spent nearly 10 years at SG Cowen, where she led that firm's investment banking in the biotech and emerging pharmaceutical sector. Previously, Ms. Grimaldi spent eight years at Goldman Sachs, and has advised companies in connection with raising public and private equity and other strategic transactions. She received a Masters in Business Administration and a Masters in International Studies from The Wharton School at the University of Pennsylvania, and a Bachelor of Science in Foreign Services degree from Georgetown University.
    Ms. Grimaldi will be based in Jefferies' New York headquarters office.

    About Jefferies

    Jefferies, a global investment bank and institutional securities firm, has served growing and mid-sized companies and their investors for over 40 years. Headquartered in New York, with more than 20 offices around the world, Jefferies provides clients with capital markets and financial advisory services, institutional brokerage, securities research and asset management. The firm is a leading provider of trade execution in equity, high yield, convertible and international securities for institutional investors and high net worth individuals. Jefferies & Company, Inc. is the principal operating subsidiary of Jefferies Group, Inc. (NYSE: JEF; www.jefco.com).

--30--MT/ny*

CONTACT: Jefferies & Company, Inc. Tom Tarrant, 203-708-5989 ttarrant@jefco.com

KEYWORD: NEW YORK INDUSTRY KEYWORD: MEDICAL BANKING MANAGEMENT CHANGES SOURCE: Jefferies & Company, Inc.

Copyright Business Wire 2005

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Nachrichten zu Jefferies Group Inc.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Jefferies Group Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Indizes in diesem Artikel

S&P 400 MidCap 1 854,40 -0,45%